Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Autologous Biologics Market Research Report 2025

Global Autologous Biologics Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 83 Pages

Report ld: 3488150

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Autologous Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Autologous Biologics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Autologous Biologics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation, Regenexx, Cytori Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Autologous Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Biologics.

The Autologous Biologics market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autologous Biologics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autologous Biologics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Vericel Corporation

BioTime, Inc.

Pharmicell Co.

BrainStorm Cell Therapeutics

Opexa Therapeutics, Inc

Pharmicell Co., Inc

Neostem

Dendreon Corporation

Regenexx

Cytori Therapeutics

Segment by Type

Adipose Tissue

Plasma

Others

Segment by Application

Hospitals

Ambulatory Centers

Research Centers

Consumption by Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Autologous Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Autologous Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Autologous Biologics Market Overview

1.1 Product Definition

1.2 Autologous Biologics by Type

1.2.1 Global Autologous Biologics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Adipose Tissue

1.2.3 Plasma

1.2.4 Others

1.3 Autologous Biologics by Application

1.3.1 Global Autologous Biologics Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Ambulatory Centers

1.3.4 Research Centers

1.4 Global Autologous Biologics Market Size Estimates and Forecasts

1.4.1 Global Autologous Biologics Revenue 2020-2031

1.4.2 Global Autologous Biologics Sales 2020-2031

1.4.3 Global Autologous Biologics Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Autologous Biologics Market Competition by Manufacturers

2.1 Global Autologous Biologics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Autologous Biologics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Autologous Biologics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Autologous Biologics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Autologous Biologics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Autologous Biologics, Product Type & Application

2.7 Global Key Manufacturers of Autologous Biologics, Date of Enter into This Industry

2.8 Global Autologous Biologics Market Competitive Situation and Trends

2.8.1 Global Autologous Biologics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Autologous Biologics Players Market Share by Revenue

2.8.3 Global Autologous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Autologous Biologics Market Scenario by Region

3.1 Global Autologous Biologics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Autologous Biologics Sales by Region: 2020-2031

3.2.1 Global Autologous Biologics Sales by Region: 2020-2025

3.2.2 Global Autologous Biologics Sales by Region: 2026-2031

3.3 Global Autologous Biologics Revenue by Region: 2020-2031

3.3.1 Global Autologous Biologics Revenue by Region: 2020-2025

3.3.2 Global Autologous Biologics Revenue by Region: 2026-2031

3.4 North America Autologous Biologics Market Facts & Figures by Country

3.4.1 North America Autologous Biologics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Autologous Biologics Sales by Country (2020-2031)

3.4.3 North America Autologous Biologics Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Autologous Biologics Market Facts & Figures by Country

3.5.1 Europe Autologous Biologics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Autologous Biologics Sales by Country (2020-2031)

3.5.3 Europe Autologous Biologics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Autologous Biologics Market Facts & Figures by Region

3.6.1 Asia Pacific Autologous Biologics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Autologous Biologics Sales by Region (2020-2031)

3.6.3 Asia Pacific Autologous Biologics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Autologous Biologics Market Facts & Figures by Country

3.7.1 Latin America Autologous Biologics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Autologous Biologics Sales by Country (2020-2031)

3.7.3 Latin America Autologous Biologics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Autologous Biologics Market Facts & Figures by Country

3.8.1 Middle East and Africa Autologous Biologics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Autologous Biologics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Autologous Biologics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Autologous Biologics Sales by Type (2020-2031)

4.1.1 Global Autologous Biologics Sales by Type (2020-2025)

4.1.2 Global Autologous Biologics Sales by Type (2026-2031)

4.1.3 Global Autologous Biologics Sales Market Share by Type (2020-2031)

4.2 Global Autologous Biologics Revenue by Type (2020-2031)

4.2.1 Global Autologous Biologics Revenue by Type (2020-2025)

4.2.2 Global Autologous Biologics Revenue by Type (2026-2031)

4.2.3 Global Autologous Biologics Revenue Market Share by Type (2020-2031)

4.3 Global Autologous Biologics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Autologous Biologics Sales by Application (2020-2031)

5.1.1 Global Autologous Biologics Sales by Application (2020-2025)

5.1.2 Global Autologous Biologics Sales by Application (2026-2031)

5.1.3 Global Autologous Biologics Sales Market Share by Application (2020-2031)

5.2 Global Autologous Biologics Revenue by Application (2020-2031)

5.2.1 Global Autologous Biologics Revenue by Application (2020-2025)

5.2.2 Global Autologous Biologics Revenue by Application (2026-2031)

5.2.3 Global Autologous Biologics Revenue Market Share by Application (2020-2031)

5.3 Global Autologous Biologics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Vericel Corporation

6.1.1 Vericel Corporation Company Information

6.1.2 Vericel Corporation Description and Business Overview

6.1.3 Vericel Corporation Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Vericel Corporation Autologous Biologics Product Portfolio

6.1.5 Vericel Corporation Recent Developments/Updates

6.2 BioTime, Inc.

6.2.1 BioTime, Inc. Company Information

6.2.2 BioTime, Inc. Description and Business Overview

6.2.3 BioTime, Inc. Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 BioTime, Inc. Autologous Biologics Product Portfolio

6.2.5 BioTime, Inc. Recent Developments/Updates

6.3 Pharmicell Co.

6.3.1 Pharmicell Co. Company Information

6.3.2 Pharmicell Co. Description and Business Overview

6.3.3 Pharmicell Co. Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Pharmicell Co. Autologous Biologics Product Portfolio

6.3.5 Pharmicell Co. Recent Developments/Updates

6.4 BrainStorm Cell Therapeutics

6.4.1 BrainStorm Cell Therapeutics Company Information

6.4.2 BrainStorm Cell Therapeutics Description and Business Overview

6.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 BrainStorm Cell Therapeutics Autologous Biologics Product Portfolio

6.4.5 BrainStorm Cell Therapeutics Recent Developments/Updates

6.5 Opexa Therapeutics, Inc

6.5.1 Opexa Therapeutics, Inc Company Information

6.5.2 Opexa Therapeutics, Inc Description and Business Overview

6.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Opexa Therapeutics, Inc Autologous Biologics Product Portfolio

6.5.5 Opexa Therapeutics, Inc Recent Developments/Updates

6.6 Pharmicell Co., Inc

6.6.1 Pharmicell Co., Inc Company Information

6.6.2 Pharmicell Co., Inc Description and Business Overview

6.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Pharmicell Co., Inc Autologous Biologics Product Portfolio

6.6.5 Pharmicell Co., Inc Recent Developments/Updates

6.7 Neostem

6.7.1 Neostem Company Information

6.7.2 Neostem Description and Business Overview

6.7.3 Neostem Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Neostem Autologous Biologics Product Portfolio

6.7.5 Neostem Recent Developments/Updates

6.8 Dendreon Corporation

6.8.1 Dendreon Corporation Company Information

6.8.2 Dendreon Corporation Description and Business Overview

6.8.3 Dendreon Corporation Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Dendreon Corporation Autologous Biologics Product Portfolio

6.8.5 Dendreon Corporation Recent Developments/Updates

6.9 Regenexx

6.9.1 Regenexx Company Information

6.9.2 Regenexx Description and Business Overview

6.9.3 Regenexx Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Regenexx Autologous Biologics Product Portfolio

6.9.5 Regenexx Recent Developments/Updates

6.10 Cytori Therapeutics

6.10.1 Cytori Therapeutics Company Information

6.10.2 Cytori Therapeutics Description and Business Overview

6.10.3 Cytori Therapeutics Autologous Biologics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Cytori Therapeutics Autologous Biologics Product Portfolio

6.10.5 Cytori Therapeutics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Autologous Biologics Industry Chain Analysis

7.2 Autologous Biologics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Autologous Biologics Production Mode & Process Analysis

7.4 Autologous Biologics Sales and Marketing

7.4.1 Autologous Biologics Sales Channels

7.4.2 Autologous Biologics Distributors

7.5 Autologous Biologics Customer Analysis

8 Autologous Biologics Market Dynamics

8.1 Autologous Biologics Industry Trends

8.2 Autologous Biologics Market Drivers

8.3 Autologous Biologics Market Challenges

8.4 Autologous Biologics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Autologous Biologics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Autologous Biologics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Autologous Biologics Market Competitive Situation by Manufacturers in 2024

Table 4. Global Autologous Biologics Sales (Kg) of Key Manufacturers (2020-2025)

Table 5. Global Autologous Biologics Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Autologous Biologics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Autologous Biologics Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Autologous Biologics Average Price (US$/Kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Autologous Biologics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Autologous Biologics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Autologous Biologics, Product Type & Application

Table 12. Global Key Manufacturers of Autologous Biologics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Autologous Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Biologics as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Autologous Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Autologous Biologics Sales by Region (2020-2025) & (Kg)

Table 18. Global Autologous Biologics Sales Market Share by Region (2020-2025)

Table 19. Global Autologous Biologics Sales by Region (2026-2031) & (Kg)

Table 20. Global Autologous Biologics Sales Market Share by Region (2026-2031)

Table 21. Global Autologous Biologics Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Autologous Biologics Revenue Market Share by Region (2020-2025)

Table 23. Global Autologous Biologics Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Autologous Biologics Revenue Market Share by Region (2026-2031)

Table 25. North America Autologous Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Autologous Biologics Sales by Country (2020-2025) & (Kg)

Table 27. North America Autologous Biologics Sales by Country (2026-2031) & (Kg)

Table 28. North America Autologous Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Autologous Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Autologous Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Autologous Biologics Sales by Country (2020-2025) & (Kg)

Table 32. Europe Autologous Biologics Sales by Country (2026-2031) & (Kg)

Table 33. Europe Autologous Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Autologous Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Autologous Biologics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Autologous Biologics Sales by Region (2020-2025) & (Kg)

Table 37. Asia Pacific Autologous Biologics Sales by Region (2026-2031) & (Kg)

Table 38. Asia Pacific Autologous Biologics Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Autologous Biologics Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Autologous Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Autologous Biologics Sales by Country (2020-2025) & (Kg)

Table 42. Latin America Autologous Biologics Sales by Country (2026-2031) & (Kg)

Table 43. Latin America Autologous Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Autologous Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Autologous Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Autologous Biologics Sales by Country (2020-2025) & (Kg)

Table 47. Middle East and Africa Autologous Biologics Sales by Country (2026-2031) & (Kg)

Table 48. Middle East and Africa Autologous Biologics Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Autologous Biologics Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Autologous Biologics Sales (Kg) by Type (2020-2025)

Table 51. Global Autologous Biologics Sales (Kg) by Type (2026-2031)

Table 52. Global Autologous Biologics Sales Market Share by Type (2020-2025)

Table 53. Global Autologous Biologics Sales Market Share by Type (2026-2031)

Table 54. Global Autologous Biologics Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Autologous Biologics Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Autologous Biologics Revenue Market Share by Type (2020-2025)

Table 57. Global Autologous Biologics Revenue Market Share by Type (2026-2031)

Table 58. Global Autologous Biologics Price (US$/Kg) by Type (2020-2025)

Table 59. Global Autologous Biologics Price (US$/Kg) by Type (2026-2031)

Table 60. Global Autologous Biologics Sales (Kg) by Application (2020-2025)

Table 61. Global Autologous Biologics Sales (Kg) by Application (2026-2031)

Table 62. Global Autologous Biologics Sales Market Share by Application (2020-2025)

Table 63. Global Autologous Biologics Sales Market Share by Application (2026-2031)

Table 64. Global Autologous Biologics Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Autologous Biologics Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Autologous Biologics Revenue Market Share by Application (2020-2025)

Table 67. Global Autologous Biologics Revenue Market Share by Application (2026-2031)

Table 68. Global Autologous Biologics Price (US$/Kg) by Application (2020-2025)

Table 69. Global Autologous Biologics Price (US$/Kg) by Application (2026-2031)

Table 70. Vericel Corporation Company Information

Table 71. Vericel Corporation Description and Business Overview

Table 72. Vericel Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Vericel Corporation Autologous Biologics Product

Table 74. Vericel Corporation Recent Developments/Updates

Table 75. BioTime, Inc. Company Information

Table 76. BioTime, Inc. Description and Business Overview

Table 77. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. BioTime, Inc. Autologous Biologics Product

Table 79. BioTime, Inc. Recent Developments/Updates

Table 80. Pharmicell Co. Company Information

Table 81. Pharmicell Co. Description and Business Overview

Table 82. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Pharmicell Co. Autologous Biologics Product

Table 84. Pharmicell Co. Recent Developments/Updates

Table 85. BrainStorm Cell Therapeutics Company Information

Table 86. BrainStorm Cell Therapeutics Description and Business Overview

Table 87. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. BrainStorm Cell Therapeutics Autologous Biologics Product

Table 89. BrainStorm Cell Therapeutics Recent Developments/Updates

Table 90. Opexa Therapeutics, Inc Company Information

Table 91. Opexa Therapeutics, Inc Description and Business Overview

Table 92. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. Opexa Therapeutics, Inc Autologous Biologics Product

Table 94. Opexa Therapeutics, Inc Recent Developments/Updates

Table 95. Pharmicell Co., Inc Company Information

Table 96. Pharmicell Co., Inc Description and Business Overview

Table 97. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Pharmicell Co., Inc Autologous Biologics Product

Table 99. Pharmicell Co., Inc Recent Developments/Updates

Table 100. Neostem Company Information

Table 101. Neostem Description and Business Overview

Table 102. Neostem Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. Neostem Autologous Biologics Product

Table 104. Neostem Recent Developments/Updates

Table 105. Dendreon Corporation Company Information

Table 106. Dendreon Corporation Description and Business Overview

Table 107. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Dendreon Corporation Autologous Biologics Product

Table 109. Dendreon Corporation Recent Developments/Updates

Table 110. Regenexx Company Information

Table 111. Regenexx Description and Business Overview

Table 112. Regenexx Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. Regenexx Autologous Biologics Product

Table 114. Regenexx Recent Developments/Updates

Table 115. Cytori Therapeutics Company Information

Table 116. Cytori Therapeutics Description and Business Overview

Table 117. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Cytori Therapeutics Autologous Biologics Product

Table 119. Cytori Therapeutics Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Autologous Biologics Distributors List

Table 123. Autologous Biologics Customers List

Table 124. Autologous Biologics Market Trends

Table 125. Autologous Biologics Market Drivers

Table 126. Autologous Biologics Market Challenges

Table 127. Autologous Biologics Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Autologous Biologics

Figure 2. Global Autologous Biologics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Autologous Biologics Market Share by Type: 2024 & 2031

Figure 4. Adipose Tissue Product Picture

Figure 5. Plasma Product Picture

Figure 6. Others Product Picture

Figure 7. Global Autologous Biologics Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Autologous Biologics Market Share by Application: 2024 & 2031

Figure 9. Hospitals

Figure 10. Ambulatory Centers

Figure 11. Research Centers

Figure 12. Global Autologous Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Autologous Biologics Market Size (2020-2031) & (US$ Million)

Figure 14. Global Autologous Biologics Sales (2020-2031) & (Kg)

Figure 15. Global Autologous Biologics Average Price (US$/Kg) & (2020-2031)

Figure 16. Autologous Biologics Report Years Considered

Figure 17. Autologous Biologics Sales Share by Manufacturers in 2024

Figure 18. Global Autologous Biologics Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Autologous Biologics Players: Market Share by Revenue in Autologous Biologics in 2024

Figure 20. Autologous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Autologous Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Autologous Biologics Sales Market Share by Country (2020-2031)

Figure 23. North America Autologous Biologics Revenue Market Share by Country (2020-2031)

Figure 24. United States Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Autologous Biologics Sales Market Share by Country (2020-2031)

Figure 27. Europe Autologous Biologics Revenue Market Share by Country (2020-2031)

Figure 28. Germany Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Autologous Biologics Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Autologous Biologics Revenue Market Share by Region (2020-2031)

Figure 35. China Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Autologous Biologics Sales Market Share by Country (2020-2031)

Figure 45. Latin America Autologous Biologics Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Autologous Biologics Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Autologous Biologics Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Autologous Biologics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Autologous Biologics by Type (2020-2031)

Figure 55. Global Revenue Market Share of Autologous Biologics by Type (2020-2031)

Figure 56. Global Autologous Biologics Price (US$/Kg) by Type (2020-2031)

Figure 57. Global Sales Market Share of Autologous Biologics by Application (2020-2031)

Figure 58. Global Revenue Market Share of Autologous Biologics by Application (2020-2031)

Figure 59. Global Autologous Biologics Price (US$/Kg) by Application (2020-2031)

Figure 60. Autologous Biologics Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Autologous Biologics market? zhanKai

The top companies in the global Autologous Biologics market are Vericel Corporation、BioTime, Inc.、Pharmicell Co..

Related Reports

Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Autologous Biologics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 130
USD 3950.00
(Single User License)
Global Autologous Biologics Market Research Report 2026
The global Autologous Biologics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 115
USD 2900.00
(Single User License)
Global Autologous Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Autologous Biologics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 78
USD 4250.00
(Single User License)
Global Autologous Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Autologous Biologics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 131
USD 4900.00
(Single User License)
Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Autologous Biologics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 97
USD 3950.00
(Single User License)

Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Autologous Biologics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 130
USD 3950.00 (Single User License)
Global Autologous Biologics Market Research Report 2026
The global Autologous Biologics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 115
USD 2900.00 (Single User License)
Global Autologous Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Autologous Biologics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 78
USD 4250.00 (Single User License)
Global Autologous Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Autologous Biologics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 131
USD 4900.00 (Single User License)
Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Autologous Biologics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 97
USD 3950.00 (Single User License)